Published in Clin Microbiol Infect on July 01, 2002
Multi-Site PCR-based CMV viral load assessment-assays demonstrate linearity and precision, but lack numeric standardization: a report of the association for molecular pathology. J Mol Diagn (2009) 1.28
Management of cytomegalovirus infection in solid organ transplantation. Nat Rev Nephrol (2010) 1.12
Six-month prophylaxis is cost effective in transplant patients at high risk for cytomegalovirus infection. J Am Soc Nephrol (2009) 1.06
Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation. J Clin Microbiol (2003) 1.03
The association of early post-transplant glucose levels with long-term mortality. Diabetologia (2011) 0.98
Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol (2004) 0.96
Cytomegalovirus infection in renal transplantation: clinical aspects, management and the perspectives. Einstein (Sao Paulo) (2015) 0.77
Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients. Pediatr Transplant (2012) 0.77
Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology (1989) 2.98
Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. Transplantation (2001) 2.13
Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol (1987) 1.85
Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol (1996) 1.84
Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis. Scand J Immunol (1976) 1.66
Lymphoepithelial interactions in the mucosal immune system. Gut (1988) 1.58
The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int (2006) 1.57
IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol (1999) 1.55
A micro assay for mouse and human interferon. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 1.50
Autonomous hyperparathyroidism in X-linked hypophosphataemia. Clin Endocrinol (Oxf) (1995) 1.50
Practice variations in the evaluation of adult candidates for cadaveric kidney transplantation: a survey of the European Transplant Centers. Transplantation (2000) 1.46
Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection. Clin Exp Immunol (2015) 1.46
[Osteoporosis drugs prescribed on blue forms!]. Tidsskr Nor Laegeforen (1995) 1.39
Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Hemophilus influenza. J Infect Dis (1968) 1.36
Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line. Scand J Immunol (1987) 1.33
Viral infection as a cause of acute peripheral facial palsy. Arch Otolaryngol (1976) 1.28
Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood (1996) 1.26
Interferon in suction blister fluid from psoriatic lesions. Br J Dermatol (1983) 1.17
Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Ann Rheum Dis (1982) 1.16
Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia (2004) 1.15
Interferon in the serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders. Acta Neurol Scand (1976) 1.14
Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice. Infect Immun (1984) 1.14
Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol (2000) 1.11
Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization. Arch Virol (1995) 1.10
Daily home spirometry facilitates early detection of rejection in single lung transplant recipients with emphysema. Eur Respir J (1993) 1.06
Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140. Mol Endocrinol (2001) 1.04
The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients. J Infect Dis (2000) 1.03
Isolation and longterm culture of human intestinal microvascular endothelial cells. Gut (1995) 1.02
Phagocytic and bactericidal activities of peritoneal and alveolar macrophages from mice. J Med Microbiol (1969) 1.02
Effect of human leukocyte interferon on invasiveness of Salmonella species in HEp-2 cell cultures. Infect Immun (1983) 1.01
Successful use of artificial lung (ECMO) and kidney in the treatment of a 20-year-old female with Wegener's syndrome. Nephrol Dial Transplant (1994) 1.00
Topographic distribution of homing receptors on B and T cells in human gut-associated lymphoid tissue: relation of L-selectin and integrin alpha 4 beta 7 to naive and memory phenotypes. Am J Pathol (1997) 1.00
Epithelial expression of HLA, secretory component (poly-Ig receptor), and adhesion molecules in the human alimentary tract. Ann N Y Acad Sci (1992) 0.99
Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor. Scand J Immunol (1973) 0.98
Synergistic effect in viral-bacterial infection. 2. Influence of viral infection on the phagocytic ability of alveolar macrophages. Acta Pathol Microbiol Scand B Microbiol Immunol (1970) 0.97
Molecular cloning and exon-intron mapping of the gene encoding human transmembrane secretory component (the poly-Ig receptor) Eur J Immunol (1992) 0.95
Production and secretion of immunoglobulins in the gastrointestinal tract. Ann Allergy (1987) 0.95
Synergistic effect in viral-bacterial infection. 3. Histopathological changes in the trachea of mice following viral and bacterial infection. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 0.95
Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology (1996) 0.94
A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients. Transplantation (2000) 0.92
Effect of human gamma interferon on invasiveness of Salmonella typhimurium in HEp-2 cell cultures. J Interferon Res (1985) 0.91
A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation. Am J Transplant (2012) 0.90
Bacteriophage typing of Staphylococcus aureus using a single concentration of phage (100 x RTD). Acta Pathol Microbiol Scand (1966) 0.90
Production of immune interferon (type II) in cocultures of mouse peritoneal macrophages and syngeneic tumour cells. Scand J Immunol (1981) 0.90
An enzyme-linked immunosorbent assay for differential quantitation of secretory immunoglobulins of the A and M isotypes in human serum. J Immunol Methods (1986) 0.89
Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system. J Neurol Sci (1975) 0.89
Elevated levels of secretory immunoglobulins A and M in serum of patients with large bowel carcinoma indicate liver metastasis. Cancer (1987) 0.88
Fatal cytomegalovirus (CMV) colitis in a patient receiving low dose prednisolone therapy. Scand J Infect Dis (1991) 0.88
Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis. Scand J Gastroenterol (1994) 0.88
Effects of interferon-alpha/beta and interferon-gamma preparations on phagocytosis by mouse peritoneal macrophages. Scand J Immunol (1984) 0.87
Pathogenesis of Sendasi virus infection in mice. On the possible role of interferon on the development of disease. Acta Pathol Microbiol Scand B (1980) 0.87
Effect of interferon preparations on the uptake of non-opsonized Escherichia coli by mouse peritoneal macrophages. Acta Pathol Microbiol Scand B (1981) 0.87
Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools. Scand J Infect Dis (1991) 0.86
Nonspecific oral immunity in individuals with HIV infection. J Acquir Immune Defic Syndr (1992) 0.86
Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention. Nephron (1996) 0.85
Tumor necrosis factor production by human granulocytes. Int Arch Allergy Appl Immunol (1991) 0.85
Renal amyloidosis in intravenous heroin addicts with nephrotic syndrome and renal failure. Clin Nephrol (2009) 0.85
Immunogenicity of yeast-derived hepatitis B vaccine from two different producers. Epidemiol Infect (1990) 0.85
Interaction of herpes simplex virus with mononuclear phagocytes is dependent on the differentiation stage of the cells. APMIS (1998) 0.84
Synergistic effect in viral-bacterial infection. 5. Functional studies on the role of the ciliary activity in the mouse trachea. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 0.84
Formation of hyaline microthrombi in the mouse. Evidence for dependence on the fibrinolytic system. Acta Pathol Microbiol Scand A (1970) 0.84
Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes. Eur J Clin Microbiol Infect Dis (1998) 0.84
Cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens in patients with cervical carcinoma. Gynecol Oncol (1985) 0.83
Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin? Lancet (1985) 0.83
T cell-epithelium interactions in relation to gut immunity. Monogr Allergy (1988) 0.83
Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection. Clin Exp Immunol (2010) 0.83
Cytomegalovirus infection induces production of human interleukin-10 in macrophages. Eur J Clin Microbiol Infect Dis (2003) 0.82
The human polyomavirus BK T antigen induces gene expression in human cytomegalovirus. Virus Res (1997) 0.82
Preventive effect of a nonviral interferon inducer, a bacterial vaccine, on experimental influenza in mice. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 0.82
Influence of polyinosinic: polycytidylic acid on the circulating white blood cells in mice. Proc Soc Exp Biol Med (1973) 0.82
Interferon-gamma stimulation of messenger RNA for human secretory component (poly-Ig receptor) depends on continuous intermediate protein synthesis. Scand J Immunol (1993) 0.82
On the possible role of interferon in infections with non-viral agents. Tex Rep Biol Med (1983) 0.82
Markers of microbial translocation predict hypertension in HIV-infected individuals. HIV Med (2013) 0.82
Histomorphometric analysis of normal bone from the iliac crest of Norwegian subjects. Bone Miner (1988) 0.81
Effect of gamma interferon preparations on in vitro phagocytosis and degradation of Escherichia coli by mouse peritoneal macrophages. J Interferon Res (1981) 0.81
Effect of a homologous beta-interferon preparation on degradation of Escherichia coli and on lysosomal enzyme activities in mouse peritoneal macrophages. Acta Pathol Microbiol Immunol Scand B (1982) 0.81
The effect of ascorbic acid on production of human interferon and the antiviral activity in vitro. Acta Pathol Microbiol Scand B (1976) 0.81
Has cytomegalovirus infection any role in the development of atherosclerosis? Clin Microbiol Infect (2002) 0.81
Effect of measles-virus infection and interferon treatment on invasiveness of Shigella flexneri in HEp2-cell cultures. J Med Microbiol (1986) 0.81
Human interferon and cell growth inhibition. I. Inhibitory effect of human interferon on the growth rate of cultured human cells. Acta Pathol Microbiol Scand B (1976) 0.81
Reproducibility of staphylococcal bacteriophage types by use of different concentrations of bacteriophage. Appl Microbiol (1967) 0.81
Cholera toxin inhibits antiviral and growth inhibitory activities of human interferon. Proc Soc Exp Biol Med (1978) 0.81
Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infection. Eur J Clin Invest (2005) 0.81
Acute peripheral facial palsy. Part of a cranial polyneuropathy? Arch Otolaryngol (1977) 0.81
Involvement of tumor necrosis factor in human granulocyte-mediated killing of WEHI 164 cells. Int Arch Allergy Appl Immunol (1989) 0.80
Attempts to isolate virus from human trigeminal and facial ganglions. Med Microbiol Immunol (1978) 0.80
Antiviral and cell multiplication inhibitory activities of mouse interferon poreparations tested on an interferon sensitive murine sarcoma cell line. Acta Pathol Microbiol Scand B (1980) 0.80
Human cytomegalovirus induced inhibition of hematopoietic cell line growth is initiated by events taking place before translation of viral gene products. Arch Virol (2000) 0.80
Lack of activity of fusidic acid against human immunodeficiency virus in monocytes. Antimicrob Agents Chemother (1989) 0.80
Interaction between viral and bacterial infections in the respiratory tract. Scand J Infect Dis Suppl (1986) 0.80
Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients. Clin Microbiol Infect (2001) 0.80
Immunophenotypic analyses of CD34(+) cell subsets in bone marrow from HIV-infected patients during highly- active antiretroviral therapy. Eur J Clin Invest (2002) 0.80